Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study on the Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules for the Treatment of Bacterial Vaginosis

NCT07418957 is registered in ClinicalTrials.gov with Guangdong Longchuangji Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07418957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07418957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study on the Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules for the Treatment of Bacterial Vaginosis
Lead sponsor
Guangdong Longchuangji Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
June 12, 2024
Completion date
July 3, 2025
Enrollment
402 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis (bv)